Anesth Pain Med.  2021 Jan;16(1):8-15. 10.17085/apm.20089.

Perioperative glucocorticoid management based on current evidence

• Seo KH

• KMID: 2512278
• DOI: http://doi.org/10.17085/apm.20089

Abstract

Glucocorticoid preparations, adreno-cortical steroids, with strong anti-inflammatory and immunosuppressive effects, are widely used for treating various diseases. The number of patients exposed to steroid therapy prior to surgery is increasing. When these patients present for surgery, the anesthesiologist must decide whether to administer perioperative steroid supplementation. Stress-dose glucocorticoid administration is required during the perioperative period because of the possibility of failure of cortisol secretion to cope with the increased cortisol requirement due to surgical stress, adrenal insufficiency, hemodynamic instability, and the possibility of adrenal crisis. Therefore, glucocorticoids should be supplemented at the same level as that of normal physiological response to surgical stress by evaluating the invasiveness of surgery and inhibition of the hypothalamus-pituitary-adrenal axis. Various textbooks and research articles recommend the stress-dose of glucocorticoids during perioperative periods. It has been commonly suggested that glucocorticoids should be administered in an amount equivalent to about 100 mg of cortisol for major surgery because it induces approximately 5 times the normal secretion. However, more studies, with appropriate power, regarding the administration of stress-dose glucocorticoids are still required, and evaluation of patients with possible adrenal insufficiency and appropriate glucocorticoid administration based on surgical stress will help improve the prognosis.

Keyword

Adrenal insufficiency; Glucocorticoids; Hypothalamus-pituitary-adrenal axis; Perioperative period; Steroid

Reference

1. Keegan MT. Endocrine Pharmacology. In: Pharmacology and physiology for anesthesia: foundations and clinical application. 2nd ed. Edited by Hemmings HC Jr, Egan TD: Philadelphia, Elsevier. 2019, pp 708-31.

2. Fraser CG, Preuss FS, Bigford WD. Adrenal atrophy and irreversible shock associated with cortisone therapy. J Am Med Assoc. 1952; 149:1542–3.

3. Lewis L, Robinson RF, Yee J, Hacker LA, Eisen G. Fatal adrenal cortical insufficiency precipitated by surgery during prolonged continuous cortisone treatment. Ann Intern Med. 1953; 39:116–26.

4. Marik PE, Varon J. Requirement of perioperative stress doses of corticosteroids: a systematic review of the literature. Arch Surg. 2008; 143:1222–6.

5. de Lange DW, Kars M. Perioperative glucocorticosteroid supplementation is not supported by evidence. Eur J Intern Med. 2008; 19:461–7.

6. Khazen BF, El-Hussuna A. The use of a perioperative supra-physiological dose of glucocorticoid is not supported by evidence - a systematic review. Dan Med J. 2018; 65:A5488.

7. Liu MM, Reidy AB, Saatee S, Collard CD. Perioperative steroid management: approaches based on current evidence. Anesthesiology. 2017; 127:166–72.

8. Woodcock T, Barker P, Daniel S, Fletcher S, Wass JAH, Tomlinson JW, et al. Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK. Anaesthesia. 2020; 75:654–63.

9. Debono M, Ghobadi C, Rostami-Hodjegan A, Huatan H, Campbell MJ, Newell-Price J, et al. Modified-release hydrocortisone to provide circadian cortisol profiles. J Clin Endocrinol Metab. 2009; 94:1548–54.

10. Esteban NV, Loughlin T, Yergey AL, Zawadzki JK, Booth JD, Winterer JC, et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab. 1991; 72:39–45.

11. Coursin DB, Wood KE. Corticosteroid supplementation for adrenal insufficiency. JAMA. 2002; 287:236–40.

12. Chrousos GP. Chapter 39: adrenocorticosteroids & adrenocortical antagonists. In: Basic & clinical pharmacology. 14th ed. Edited by Katzung BG: New York, McGraw-Hill. 2018.

13. MacKenzie CR, Goodman SM. Stress dose steroids: myths and perioperative medicine. Curr Rheumatol Rep. 2016; 18:47.

14. Woods CP, Argese N, Chapman M, Boot C, Webster R, Dabhi V, et al. Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol. Eur J Endocrinol. 2015; 173:633–42.

15. Garcia JEL, Hill GE, Joshi GP. Perioperative stress dose steroids: is it really necessary? ASA Newsl. 2013; 77:32–5.

16. Kehlet H, Binder C. Adrenocortical function and clinical course during and after surgery in unsupplemented glucocorticoid-treated patients. Br J Anaesth. 1973; 45:1043–8.

17. Salem M, Tainsh RE Jr, Bromberg J, Loriaux DL, Chernow B. Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem. Ann Surg. 1994; 219:416–25.

18. Prete A, Yan Q, Al-Tarrah K, Akturk HK, Prokop LJ, Alahdab F, et al. The cortisol stress response induced by surgery: a systematic review and meta-analysis. Clin Endocrinol (Oxf). 2018; 89:554–67.

19. Donati A, Ruzzi M, Adrario E, Pelaia P, Coluzzi F, Gabbanelli V, et al. A new and feasible model for predicting operative risk. Br J Anaesth. 2004; 93:393–9.

20. Lamberts SW, Bruining HA, de Jong FH. Corticosteroid therapy in severe illness. N Engl J Med. 1997; 337:1285–92.

21. Glowniak JV, Loriaux DL. A double-blind study of perioperative steroid requirements in secondary adrenal insufficiency. Surgery. 1997; 121:123–9.

22. Thomason JM, Girdler NM, Kendall-Taylor P, Wastell H, Weddel A, Seymour RA. An investigation into the need for supplementary steroids in organ transplant patients undergoing gingival surgery. A double-blind, split-mouth, cross-over study. J Clin Periodontol. 1999; 26:577–82.

23. Zaghiyan K, Melmed GY, Berel D, Ovsepyan G, Murrell Z, Fleshner P. A prospective, randomized, noninferiority trial of steroid dosing after major colorectal surgery. Ann Surg. 2014; 259:32–7.

24. Axelrod L. Perioperative management of patients treated with glucocorticoids. Endocrinol Metab Clin North Am. 2003; 32:367–83.

25. Axelrod L. Inhibition of prostacyclin production mediates permissive effect of glucocorticoids on vascular tone. Perturbations of this mechanism contribute to pathogenesis of Cushing's syndrome and Addison's disease. Lancet. 1983; 1:904–6.

26. Wong DL, Siddall B, Wang W. Hormonal control of rat adrenal phenylethanolamine N-methyltransferase. Enzyme activity, the final critical pathway. Neuropsychopharmacology. 1995; 13:223–34.

27. Shi LJ, He HY, Liu LA, Wang CA. Rapid nongenomic effect of corticosterone on neuronal nicotinic acetylcholine receptor in PC12 cells. Arch Biochem Biophys. 2001; 394:145–50.

28. Sabourdin N. Steroids: the evidence. The rationale for perioperative glucocorticoid supplementation for patients under chronic steroid treatment. Curr Anesthesiol Rep. 2015; 5:140–6.

29. Bhaskar M, Stith RD, Brackett DJ, Wilson MF, Lerner MR, Reddy YS. Changes in myocardial contractile protein ATPases in chronically adrenalectomized rats with and without glucocorticoid replacement. Biochem Med Metab Biol. 1989; 42:118–24.

30. Bouachour G, Tirot P, Varache N, Gouello JP, Harry P, Alquier P. Hemodynamic changes in acute adrenal insufficiency. Intensive Care Med. 1994; 20:138–41.

31. Czock D, Keller F, Rasche FM, Häussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005; 44:61–98.

32. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. N Engl J Med. 2005; 353:1711–23.

33. Sato S, Kim T, Arai T, Maruyama S, Tajima M, Utsumi N. Comparison between the effects of dexamethasone and indomethacin on bone wound healing. Jpn J Pharmacol. 1986; 42:71–8.

34. Freudzon L. Perioperative steroid therapy: where's the evidence? Curr Opin Anaesthesiol. 2018; 31:39–42.

35. Todd GR, Acerini CL, Ross-Russell R, Zahra S, Warner JT, McCance D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child. 2002; 87:457–61.

36. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med. 1999; 159:941–55.

37. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006; 54:1–15.

38. Lansang MC, Farmer T, Kennedy L. Diagnosing the unrecognized systemic absorption of intra-articular and epidural steroid injections. Endocr Pract. 2009; 15:225–8.

39. Hägg E, Asplund K, Lithner F. Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency. Clin Endocrinol (Oxf). 1987; 26:221–6.

40. McConachie I. Peri-operative glucocorticoid guidelines. Anaesthesia. 2020; 75:1394.

41. Vercueil A; Working Party. Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: a reply. Anaesthesia. 2020; 75:1398–9.